Gama Paul sold $488K of PG

Gama Paul (CEO- Health Care) sold 3,396 shares of PROCTER & GAMBLE Co (PG) at $143.79 ($0.49M total) on 2026-08-20.

Original reporting
SEC EDGAR · Gama Paul
Published Aug 24, 2026, 7:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 7:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PG
Bearish
medium confidence
Mentioned
$PG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGBearishLow
01

Why it matters

The disclosed sale is modest but may affect short-term sentiment.

02

Market read

Insider sale of $0.5M in a large-cap consumer staple may cause slight price movement.

03

What to watch

Sale price $143.79 is above recent market price, indicating possible profit taking.

Relevance 4/10Novelty 4/10Timing: post-filing 2026-08-24

Background

Form 4 filings disclose insider transactions; investors monitor them for signals.

Company-level read

Ticker impact

$PGBearishMedium confidence
Context

CEO Gama Paul sold 3,396 shares of Procter & Gamble for $488,310, reducing his stake to 40,832 shares.

Expected impact

Possible modest dip in PG price over the next few days.

Evidence & confidence

Sale size is modest relative to market cap, but insider activity often influences sentiment.

Market effects

Minimal impact on consumer staples sector.

U.S. market only.

Low

Counterpoint

Insider sale may be routine portfolio diversification, not a negative signal.

Key entities

  • Procter & Gamble Co

    Consumer goods conglomerate (ticker PG).

  • Gama Paul

    CEO of Health Care division at Procter & Gamble.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of $750,000,000 aggregate principal amount of 5.125% Notes due October 30, 2031…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On October 30, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 5.125% Notes due October 30, 2031, $750,000,000 aggregate principal amount of 5.300% Notes due October 30